Grant

Grant RDF

pages:

Host-bacterial Determinants of Cardiac Damage and Invasive Pneumococcal Disease
Host-Microbe Cross-Talk and Pregnancy Outcomes
Housing, Caring, Feeding/Nourishment of Research Animals for the Birmingham VA Medical Center
Housing, Caring, Feeding/Nourishment of Research Animals for the Birmingham VA Medical Center
How Inflammation and High Density Lipoproteins Affect the Relationship Between APOL 1 and Outcomes
How Much is an Educator Worth? Translation Education Activities into Work RVU Equivalents: The Education Value Unit (EVU)
How to be FAIR: A Self-study Program for Integrating FAIR Principles into Best Data Management Practices
How to be FAIR: A Self-study Program for Integrating FAIR Principles into Best Data Management Practices
How to Control Access to Thousands of Shared Devices on the loT
Howard Huges Med Into Grad Fellowship Program
Howard Hughes Med Into Grad Fellowship Program
Howard Hughes Medical Institute Fellows Award
HPS 3/TIMI 55-Reveal (Randomized Evaluation of the Effects of Anacetrapib through Lipid-Modification)
HPS 3/TIMI 55: REVEAL (Randomized EValuation of the Effects of Anacetrapib through Lipid-modification)
HPS-4/TIMI 65/ORION-4: A double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People with Atherosclerotic Cardiovascular Disease
HPTN 078: Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected Men Who Have Sex with Men (MSM) in the United States
HPTN 083 A Phase 2b/3 Double Blind Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender
HPTN 083-A Phase 2b/3 Double Blind Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women who have Sex with Men (ViiV)
HPTN Leadership Biomedical Committee Chair
HPTN O83 Protocol Funds
HPTN Personal Protective Equipment- HPTN Studies
HPTN Unanticipated Clinical Trials Costs
HPV Clearance by Folic Acid Supplementation
HPV Clearance by Folic Acid Supplementation
HPV E5 as a Target for Therapeutics to Treat Precancerous and Benign HPV Lesions
HPX3002/HVTN 706 Protocol Funding (PF)
HSET as a Racial Disparity Biomarker for TNBC Patients
HSET As A Racial Disparity Biomarker for TNBC Patients
HSF GEF Scholar Award - Michal Mrug
HSF-GEF Research Acceleration Award - Benveniste

pages: